What question did this study set out to answer?

To review the clinical accuracy, limitations, and practical applications of noninvasive modalities, including serum biomarker panels and elastography imaging, for assessing liver fibrosis compared to percutaneous liver biopsy.

May 5, 2011Hepatology

Noninvasive assessment of liver fibrosis

View Full Paper

Ask AI

Bookmark

Authors

DNDoris NguyenMayo Clinic JTJayant A. TalwalkarUniversity of Pisa

Discussion

Member takes

Implication

Clinical review evaluates noninvasive diagnostic tools for liver fibrosis staging in chronic liver disease, highlighting their ability to rule in or out cirrhosis without biopsy.

Key Points

To review the clinical accuracy, limitations, and practical applications of noninvasive modalities, including serum biomarker panels and elastography imaging, for assessing liver fibrosis compared to percutaneous liver biopsy.
Reviewed diagnostic performance of indirect serum panels (FibroTest), ultrasound-based transient elastography (TE), and magnetic resonance elastography (MRE) across published clinical trials and meta-analyses.
Evaluated technical requirements, confounders (such as obesity, inflammation, and cholestasis), and regulatory and economic factors across modalities.
Synthesized evidence within the context of a 48-year-old male with chronic hepatitis C genotype 1b undergoing fibrosis staging.
Both TE and MRE show excellent pooled diagnostic accuracy for detecting cirrhosis (stage F4), with sensitivity and specificity values exceeding 90%.
For detecting intermediate to significant fibrosis (stages F2–F4), MRE achieves higher sensitivity and specificity (80%–85%) compared to TE (pooled sensitivity and specificity of 70%–80%).
Serum panels like FibroTest reliably detect cirrhosis but show diminished accuracy for intermediate fibrosis stages and are susceptible to false positives from hemolysis, hyperbilirubinemia, or systemic inflammation.

Cite This Study

Nguyen et al. (2011) studied this question.

synapsesocial.com/papers/6a721972a7fbea1e44089691 https://doi.org/10.1002/hep.24401

View Full Paper

Ask AI

Bookmark

May 5, 2011Hepatology

Noninvasive assessment of liver fibrosis

View Full Paper

Ask AI

Bookmark

Authors

DNDoris NguyenMayo Clinic JTJayant A. TalwalkarUniversity of Pisa

Discussion

Member takes

Implication

Clinical review evaluates noninvasive diagnostic tools for liver fibrosis staging in chronic liver disease, highlighting their ability to rule in or out cirrhosis without biopsy.

Key Points

To review the clinical accuracy, limitations, and practical applications of noninvasive modalities, including serum biomarker panels and elastography imaging, for assessing liver fibrosis compared to percutaneous liver biopsy.
Reviewed diagnostic performance of indirect serum panels (FibroTest), ultrasound-based transient elastography (TE), and magnetic resonance elastography (MRE) across published clinical trials and meta-analyses.
Evaluated technical requirements, confounders (such as obesity, inflammation, and cholestasis), and regulatory and economic factors across modalities.
Synthesized evidence within the context of a 48-year-old male with chronic hepatitis C genotype 1b undergoing fibrosis staging.
Both TE and MRE show excellent pooled diagnostic accuracy for detecting cirrhosis (stage F4), with sensitivity and specificity values exceeding 90%.
For detecting intermediate to significant fibrosis (stages F2–F4), MRE achieves higher sensitivity and specificity (80%–85%) compared to TE (pooled sensitivity and specificity of 70%–80%).
Serum panels like FibroTest reliably detect cirrhosis but show diminished accuracy for intermediate fibrosis stages and are susceptible to false positives from hemolysis, hyperbilirubinemia, or systemic inflammation.

Cite This Study

Nguyen et al. (2011) studied this question.

synapsesocial.com/papers/6a721972a7fbea1e44089691 https://doi.org/10.1002/hep.24401

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark